NewsAAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyHealthDay.comMarch 6, 2026
NewsAAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for OsteoporosisHealthDay.comMarch 6, 2026
Subset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based ChemoimmunotherapyMarch 6, 2026
NewsJudge Says More Answers Needed About Relocation of COVID-19 PatientsHealthDay.comFebruary 25, 2020
